Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

Samaritan inks collaboration with McGill University
September 2007
SHARING OPTIONS:

LAS VEGASóSamaritan Pharmaceuticals Inc., and Samaritan Therapeutics, Canada, recently  announce they signed a research collaboration and licensing agreement with The Research Institute of McGill University Health Centre (RI-MUHC) in Montreal to advance its pipeline into clinical trial status and develop new innovative drug candidates. Under the agreement, RI-MUHC will continue to develop the drug pipeline which was originally developed in the Georgetown University/Samaritan collaboration, and in addition, take potential new drug candidates through the discovery process. Once drug candidates, are clinically validated and deemed to hold promise, Samaritan Therapeutics will continue to develop the drug candidate in Canada, while Samaritan Pharmaceuticals will focus on the drug candidate's process through regulatory agencies and its commercialization.  

Back



PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2019 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.